Active, not recruitingNCT05092282
HITT for the Identification of Mild Traumatic Brain Injury
Studying Classic heparin-induced thrombocytopenia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rebiscan, Inc.
- Principal Investigator
- Ramon Diaz-Arrastia, MD, PhDUniversity of Pennsylvania
- Intervention
- Head and Intraocular Trauma Tool(device)
- Enrollment
- 200 enrolled
- Eligibility
- 13-45 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States
Collaborators
University of Pennsylvania
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05092282 on ClinicalTrials.govOther trials for Classic heparin-induced thrombocytopenia
Additional recruiting or active studies for the same condition.
See all trials for Classic heparin-induced thrombocytopenia →